Summary
Evidence for immunological participation in the pathogenesis of certain connective tissue diseases is used to argue the validity of an immunological approach to the aetiology and the treatment of rheumatoid arthritis.
The author’s experience of treating nine cases with azathiaprine is given.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
ARA Symposium 1973. Cytotoxic Drugs in Rheumatic Diseases. Arthr. Rheum., 16, 79–96.
Brewerton, D. A., Caffrey, M., Hart, F. D., James, D. C. O., Nicholls, A., Sturrock, R. D. 1973. Ankylosing spondylitis and HL A 27. Lancet i, 904.
Cathcart, E. S., Mullarkey, M., Cohen, A. S. 1972. Amyloid-inducing factor and immunological unresponsiveness. Ann. rheum. Dis., 31, 303.
Dumonde, D. C., Glynn, L. E. 1972. Production of arthritis in rabbits by an immunological reaction to fibrin. Br. J. exp. Path., 43, 373.
Klemperer, P., Pollack, A. D., Baehr, G. 1942. Diffuse coliagen disease. J. Amer. Med. Ass., 119, 331.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roberts, S.D. Immunosuppression and rheumatoid arthritis. I.J.M.S. 144 (Suppl 1), 21–28 (1975). https://doi.org/10.1007/BF02937886
Issue Date:
DOI: https://doi.org/10.1007/BF02937886